Basaglar Kwikpen Solution for Injection (3ml pre-filled pen)

What is Basaglar KwikPen 100 unit/ml

Basaglar KwikPen 100 unit/ml contains FDA-approved Insulin Glargine, a long-acting basal Insulin analog. This prescription medication helps manage blood glucose levels in adults and children above 2 with Type 1 Diabetes and adults with Type 2 Diabetes.

The pen-injector delivers precise doses ranging from 1-80 units per injection. Eli Lilly and Company manufactures this trusted Insulin therapy solution in GMP-compliant facilities. The medication provides 24-hour glucose control with once-daily dosing.

Each 3ml pen contains 300 units of Insulin Glargine in a clear, colorless solution.

Common Basaglar side effects include injection site reactions, Hypoglycemia, and weight gain. Store unopened pens in the refrigerator between 36-46°F.

Once in use, keep at room temperature below 86°F for a maximum of 28 days. Never freeze or shake the pen. Always prime before first use and rotate injection sites to prevent lipodystrophy.

Monitor blood sugar regularly and adjust dosage only under medical supervision. Dispose of used pens safely in sharps containers.

What are the benefits of Basaglar KwikPen 100 unit/ml

Basaglar KwikPen 100 unit/ml provides consistent 24-hour basal Insulin coverage through its advanced Insulin Glargine formulation. This long-acting Insulin mimics natural basal Insulin secretion, maintaining steady glucose levels between meals and overnight.

The KwikPen delivery system offers convenient, accurate dosing with easy-to-read dose windows. Pre-filled pens eliminate vial handling and reduce dosing errors.

Key therapeutic benefits include improved glycemic control, reduced risk of diabetic complications, and flexible meal timing. Compared to intermediate-acting Insulin, the predictable absorption profile minimizes nocturnal Hypoglycemia.

Clinical studies demonstrate effective HbA1c reduction while maintaining safety profiles. The pen's portability supports active lifestyles and travel convenience for Diabetes management.

How to take Basaglar KwikPen 100 unit/ml

Basaglar KwikPen 100 unit/ml is a prescription medication administered once daily at the same time. Always follow your doctor's instructions for safe administration. If you are not trained to use it, seek medical guidance.

Here are the general guidelines:

• Inject subcutaneously in the thigh, upper arm, or abdomen. Rotate injection sites within the same region to prevent tissue damage.
• Prime pen with 2 units before the first use of each new pen. Inject immediately after dose selection to prevent insulin leakage. Do not dilute or mix with other Insulins.
• Do not exceed the prescribed dosage.

Strengths and substitutes

The strengths and substitutes available for Basaglar are:

View all substitutes

What are the side effects of Basaglar KwikPen 100 unit/ml

Basaglar KwikPen 100 unit/ml is generally well-tolerated when used appropriately.

However, it may cause side effects, including:

• Hypoglycemia (low blood sugar)
• Redness
• Swelling
• Itching
• Weight gain
• Peripheral edema

These adverse effects typically resolve as your body adjusts to treatment. Severe Hypoglycemia or persistent effects require immediate medical attention.

Safety Advice

Liver disease

Patients with hepatic impairment may require reduced Insulin doses due to decreased glucose production and slower Insulin metabolism. Regular blood glucose monitoring is essential. Liver function affects Insulin clearance, potentially increasing Hypoglycemia risk. Consult healthcare providers for appropriate dose adjustments.

Kidney impairment

Renal dysfunction can alter Insulin requirements and increase Hypoglycemia risk. Patients with kidney disease need frequent glucose monitoring and potential dose reductions. Insulin elimination decreases with declining kidney function. Medical supervision ensures safe and effective Diabetes management.

Pregnant and breastfeeding women

Basaglar KwikPen 100 unit/ml is generally safe during pregnancy for managing Diabetes. Insulin requirements often change throughout pregnancy, requiring close monitoring. Breastfeeding mothers may need dose adjustments as lactation affects glucose metabolism. Regular consultation with healthcare providers ensures optimal outcomes.

Avoid

Avoid alcohol consumption as it can mask Hypoglycemia symptoms and affect blood glucose levels. Do not skip meals after an Insulin injection to prevent dangerous blood sugar drops. Avoid extreme temperature exposure to the pen. Certain medications like beta-blockers may mask Hypoglycemia warning signs.